Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Hata Yujiro S. Director active across 1 company, notably IDEAYA Biosciences, Inc.. In total, 7 disclosures have been logged. Activity tracked since 12 April 2023. The latest transaction was filed on 18 February 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Hata Yujiro S is President and CEO of IDEAYA Biosciences, Inc. He has 7 filings in total, and across the sampled recent filings from 2023-04-13 to 2025-02-19, the dominant transaction nature is Option exercise, with sum_buy_eur at 0 and sum_sell_eur at 0.